IFRX

InflaRx N.V.

Price Chart

No historical data available

Latest Quote

$2.13

-0.10 (-4.48%)

Current Price

Previous Close	$2.23
Open	$2.22
Day High	$2.23
Day Low	$2.09
Volume	447,308

Fetched: 2026-08-31T21:25:18

Stock Information

Note: Financial values converted from EUR to USD

Shares Outstanding	147.37M
Total Debt	$968K
Cash Equivalents	$184.21M
Revenue	$-12K
Net Income	$-45.49M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$313.89M
EPS (TTM)	$-0.58
Exchange	NMS

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About InflaRx N.V.

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator to treat variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a a first-in-class monoclonal anti-human complement factor C5a antibody, which is in Phase 3 clinical trial for the treatment for patients suffering from early septic organ dysfunction, biological proof of concept was established, demonstrating its unique C5a blocking ability and selectivity; Izicopan, an oral, low molecular weight drug to target C5aR with high affinity and selectivity has completed completing Phase 2a trials; and IFX002, an advancement of vilobelimab technology, which is in preclinical development for the treatment of chronic inflammatory indications. It has co-development agreement with Staidson (Beijing) BioPharmaceuticals Co., Ltd.; Cell line sales agreement with Catalent Pharma Solutions LLC; Clinical Trial Collaboration Agreement with the U.S. DHHSs, Administration for Strategic Preparedness and Response (ASPR), BARDA and PPD Development, L.P., or PPD. InflaRx N.V. was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. The company was founded in 2007 and is headquartered in Jena, Germany.

📰 Latest News

No news articles available at the moment. Check back later for updates on IFRX.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Reconciled Cost Of Revenue	$8,414,237	$3,820,363	$548,968	$0
Cost Of Revenue	$8,445,809	$3,854,781	$618,550	$0
Total Revenue	$34,086	$192,666	$73,317	$0
Operating Revenue	$34,086	$192,666	$73,317	$0
Expenses
Interest Expense	$45,600	$24,003	$41,404	$52,586
Total Expenses	$56,114,244	$61,675,038	$51,897,672	$37,464,112
Other Income Expense	$963,726	$4,265,236	$-2,140,467	$2,838,230
Net Non Operating Interest Income Expense	$2,099,000	$3,691,061	$4,380,243	$361,369
Total Other Finance Cost	$-6,602,544	$-120,029	$-364,021	$293,400
Interest Expense Non Operating	$45,600	$24,003	$41,404	$52,586
Operating Expense	$47,668,436	$57,820,257	$51,279,123	$37,464,112
Other Operating Expenses	$-3,090,294	$-6,264,502	$-15,721,678	$-23,425,669
Selling And Marketing Expense	$2,377,970	$4,695,291	$2,214,690	$0
General And Administrative Expense	$18,034,327	$17,763,209	$16,521,104	$16,668,495
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-53,031,705	$-53,532,137	$-49,584,580	$-34,264,512
Net Interest Income	$2,099,000	$3,691,061	$4,380,243	$361,369
Interest Income	$2,144,600	$3,715,065	$4,421,647	$707,355
Normalized Income	$-53,793,048	$-56,901,673	$-47,444,112	$-37,102,742
Net Income From Continuing And Discontinued Operation	$-53,031,705	$-53,532,137	$-49,584,580	$-34,264,512
Total Operating Income As Reported	$-56,083,001	$-61,602,401	$-52,188,376	$-37,464,111
Net Income Common Stockholders	$-53,031,705	$-53,532,137	$-49,584,580	$-34,264,512
Net Income	$-53,031,705	$-53,532,137	$-49,584,580	$-34,264,512
Net Income Including Noncontrolling Interests	$-53,031,706	$-53,532,138	$-49,584,580	$-34,264,513
Net Income Continuous Operations	$-53,031,706	$-53,532,138	$-49,584,580	$-34,264,513
Pretax Income	$-53,017,433	$-53,526,076	$-49,584,580	$-34,264,513
Interest Income Non Operating	$2,144,600	$3,715,065	$4,421,647	$707,355
Operating Income	$-56,080,158	$-61,482,372	$-51,824,356	$-37,464,112
Depreciation Amortization Depletion Income Statement	$455,916	$529,340	$590,244	$611,650
Depreciation And Amortization In Income Statement	$455,916	$529,340	$590,244	$611,650
Gross Profit	$-8,411,723	$-3,662,115	$-545,233	$0
Per Share
Diluted EPS	$-0.79	$-0.91	$-0.91	$-0.78
Basic EPS	$-0.79	$-0.91	$-0.91	$-0.78
Other
Tax Effect Of Unusual Items	$202,382	$895,699	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-53,448,071	$-57,203,549	$-46,742,883	$-36,356,843
Total Unusual Items	$963,726	$4,265,236	$-2,140,467	$2,838,230
Total Unusual Items Excluding Goodwill	$963,726	$4,265,236	$-2,140,467	$2,838,230
Reconciled Depreciation	$487,488	$563,758	$659,826	$693,314
EBITDA (Bullshit earnings)	$-52,484,345	$-52,938,314	$-48,883,350	$-33,518,613
EBIT	$-52,971,833	$-53,502,072	$-49,543,176	$-34,211,927
Diluted Average Shares	$78,196,774	$68,470,285	$63,846,763	$51,374,637
Basic Average Shares	$78,196,774	$68,470,285	$63,846,763	$51,374,637
Diluted NI Availto Com Stockholders	$-53,031,705	$-53,532,137	$-49,584,580	$-34,264,512
Tax Provision	$14,273	$6,063	$0	$0
Gain On Sale Of Security	$963,726	$4,265,236	$-2,140,467	$2,838,230
Research And Development	$29,890,516	$41,096,919	$47,674,762	$43,609,636
Selling General And Administration	$20,412,297	$22,458,501	$18,735,794	$16,668,495
Other Gand A	$6,566,681	$6,098,578	$6,440,503	$5,389,998
Insurance And Claims	$1,081,527	$1,824,919	$2,248,553	$2,708,453
Salaries And Wages	$10,386,119	$9,839,712	$7,832,047	$8,570,043

Fetched: 2026-08-31

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$48,244,658	$71,313,494	$119,131,804	$102,510,795
Total Assets	$64,167,693	$88,342,197	$139,696,172	$119,000,191
Total Non Current Assets	$1,838,245	$5,069,090	$12,481,196	$5,797,330
Other Non Current Assets	$1	$1	-	$1
Non Current Prepaid Assets	$175,709	$237,342	$298,974	$358,008
Investmentin Financial Assets	$275,855	$3,593,597	$10,520,327	$3,371,182
Goodwill And Other Intangible Assets	$49,105	$59,013	$79,974	$161,424
Other Intangible Assets	$49,105	$59,013	$79,974	$161,424
Current Assets	$62,329,447	$83,273,106	$127,214,976	$113,202,861
Other Current Assets	$3,024,507	$6,044,563	$108,639	$2,965,800
Prepaid Assets	$3,656,260	$5,791,779	$4,582,413	$13,501,965
Inventory	$0	$8,015,882	$13,210,700	$0
Receivables	$1,659,998	$2,016,659	$4,406,234	$1,664,250
Taxes Receivable	$1,659,998	$2,016,659	$4,406,234	$1,664,250
Cash Cash Equivalents And Short Term Investments	$53,988,682	$61,404,223	$104,906,990	$95,070,847
Cash And Cash Equivalents	$18,619,607	$21,355,004	$14,837,819	$18,902,213
Cash Equivalents	$17,136,005	$16,395,675	$5,974,377	$3,977
Cash Financial	$1,483,601	$4,959,329	$8,863,443	$18,898,237
Debt
Total Debt	$1,043,482	$935,603	$1,301,621	$1,576,622
Long Term Debt And Capital Lease Obligation	$744,884	$463,761	$866,608	$1,147,364
Current Debt And Capital Lease Obligation	$298,597	$471,842	$435,013	$429,257
Liabilities
Total Liabilities Net Minority Interest	$15,873,930	$16,969,690	$20,484,395	$16,327,973
Total Non Current Liabilities Net Minority Interest	$787,740	$506,616	$909,463	$1,190,220
Other Non Current Liabilities	$42,855	$42,855	$42,855	$42,855
Current Liabilities	$15,086,190	$16,463,075	$19,574,932	$15,137,753
Other Current Liabilities	$7,159,885	$350,430	$3,353,598	$171,537
Payables And Accrued Expenses	$6,274,705	$13,241,409	$13,915,587	$5,796,093
Payables	$6,274,705	$13,241,409	$13,915,587	$5,796,093
Accounts Payable	$6,274,705	$13,241,409	$13,915,587	$5,796,093
Current Deferred Liabilities	-	-	$0	$7,215,882
Equity
Common Stock Equity	$48,293,763	$71,372,507	$119,211,779	$102,672,218
Total Equity Gross Minority Interest	$48,293,763	$71,372,506	$119,211,777	$102,672,218
Stockholders Equity	$48,293,763	$71,372,507	$119,211,779	$102,672,218
Other Equity Interest	$8,333,968	$8,646,729	$8,578,927	$8,433,563
Gains Losses Not Affecting Retained Earnings	$56,432,890	$51,267,708	$46,542,771	$42,574,742
Other Equity Adjustments	$56,432,890	$51,267,708	$46,542,771	$42,574,742
Retained Earnings	$-439,077,301	$-386,045,596	$-332,513,459	$-282,928,879
Other
Ordinary Shares Number	$84,012,623	$68,973,518	$68,429,140	$51,950,918
Share Issued	$84,012,623	$68,973,518	$68,429,140	$51,950,918
Tangible Book Value	$48,244,658	$71,313,494	$119,131,804	$102,510,795
Invested Capital	$48,293,763	$71,372,507	$119,211,779	$102,672,218
Working Capital	$47,243,257	$66,810,032	$107,640,044	$98,065,108
Capital Lease Obligations	$1,043,482	$935,603	$1,301,621	$1,576,622
Total Capitalization	$48,293,763	$71,372,507	$119,211,779	$102,672,218
Additional Paid In Capital	$412,522,691	$389,226,844	$388,392,042	$328,358,681
Capital Stock	$10,081,515	$8,276,822	$8,211,497	$6,234,111
Common Stock	$10,081,515	$8,276,822	$8,211,497	$6,234,111
Long Term Capital Lease Obligation	$744,884	$463,761	$866,608	$1,147,364
Current Capital Lease Obligation	$298,597	$471,842	$435,013	$429,257
Pensionand Other Post Retirement Benefit Plans Current	$1,353,003	$2,399,393	$1,870,733	$1,524,983
Investments And Advances	$275,855	$3,593,597	$10,520,327	$3,371,182
Available For Sale Securities	$275,855	$3,593,597	$10,520,327	-
Net PPE	$1,337,575	$1,179,137	$1,581,921	$1,906,715
Accumulated Depreciation	$-4,326,016	$-4,008,577	$-3,446,292	$-2,925,140
Gross PPE	$5,663,591	$5,187,713	$5,028,213	$4,831,855
Other Properties	$1,786,238	$1,789,739	$1,733,324	$1,688,947
Machinery Furniture Equipment	$282,089	$282,089	$202,364	$145,415
Buildings And Improvements	$3,595,263	$3,115,885	$3,092,525	$2,997,492
Properties	$0	$0	$0	$0
Finished Goods	$0	$65,807	$383,599	$0
Work In Process	$0	$7,854,680	$12,334,874	$0
Raw Materials	$0	$95,395	$492,225	$0
Other Short Term Investments	$35,369,075	$40,049,220	$90,069,171	$76,168,633
Current Deferred Revenue	-	-	$0	$7,215,882
Held To Maturity Securities	-	-	$10,520,327	$3,371,182
Construction In Progress	-	-	$0	$0
Other Inventories	-	-	$1	-
Current Accrued Expenses	-	-	-	$3,975,756

Fetched: 2026-08-31

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-41,173,764	$-56,482,932	$-44,037,266	$-39,401,754
Operating Activities
Operating Cash Flow	$-41,039,314	$-56,428,463	$-43,943,019	$-39,213,037
Cash Flow From Continuing Operating Activities	$-41,039,313	$-56,428,464	$-43,943,018	$-39,213,037
Operating Gains Losses	$815,428	$-43,116	$479,973	$447,832
Investing Activities
Capital Expenditure	$-134,450	$-54,469	$-94,248	$-188,717
Investing Cash Flow	$3,757,174	$60,853,406	$-20,565,505	$22,496,335
Cash Flow From Continuing Investing Activities	$3,757,175	$60,853,405	$-20,565,505	$22,496,335
Net Other Investing Changes	$-1	$1	-	-
Financing Activities
Issuance Of Capital Stock	$26,613,425	$1,276,338	$65,640,827	$2,730,534
Financing Cash Flow	$38,717,777	$449,095	$61,576,143	$2,251,550
Cash Flow From Continuing Financing Activities	$38,717,779	$449,095	$61,576,143	$2,251,550
Net Other Financing Charges	$-2,489,868	$-376,210	$-3,905,434	$-55,474
Net Common Stock Issuance	$26,613,425	$1,276,338	$65,640,827	$2,730,534
Common Stock Issuance	$26,613,425	$1,276,338	$65,640,827	$2,730,534
Other
Repayment Of Debt	$-415,553	$-451,033	$-434,604	$-423,510
End Cash Position	$18,619,607	$21,355,003	$14,837,819	$18,902,215
Beginning Cash Position	$21,355,003	$14,837,819	$18,902,215	$30,505,516
Effect Of Exchange Rate Changes	$-4,171,033	$1,643,145	$-1,132,015	$2,861,850
Changes In Cash	$1,435,637	$4,874,039	$-2,932,380	$-14,465,151
Proceeds From Stock Option Exercised	$15,009,773	$0	$275,355	$0
Net Issuance Payments Of Debt	$-415,553	$-451,033	$-434,604	$-423,510
Net Long Term Debt Issuance	$-415,553	$-451,033	$-434,604	$-423,510
Long Term Debt Payments	$-415,553	$-451,033	$-434,604	$-423,510
Net Investment Purchase And Sale	$3,891,625	$60,907,875	$-20,471,257	$22,685,052
Sale Of Investment	$57,465,497	$101,977,147	$100,449,111	$97,611,892
Purchase Of Investment	$-53,573,872	$-41,069,272	$-120,920,368	$-74,926,840
Net Intangibles Purchase And Sale	$-134,450	$-54,469	$-94,248	$-188,717
Purchase Of Intangibles	$-134,450	$-54,469	$-94,248	$-188,717
Interest Received Cfo	$2,019,985	$2,606,853	$2,013,113	$1,495,875
Interest Paid Cfo	$-40,063	$-24,479	$-41,865	$-52,232
Change In Working Capital	$5,643,372	$-2,647,952	$1,166,281	$-11,357,952
Change In Other Working Capital	$-1,046,391	$528,660	$345,750	$-74,403
Change In Other Current Liabilities	$66,717	$-3,003,170	$-4,033,820	$-2,418,746
Change In Other Current Assets	$5,573,868	$-4,694,084	$9,945,558	$-4,696,637
Change In Payables And Accrued Expense	$-6,966,705	$-674,177	$8,119,494	$-4,168,165
Change In Payable	$-6,966,705	$-674,177	$8,119,494	$-4,168,165
Change In Inventory	$8,015,882	$5,194,818	$-13,210,700	$0
Other Non Cash Items	$-2,099,001	$-8,076,326	$-2,603,797	$-3,199,599
Stock Based Compensation	$5,165,182	$4,724,936	$3,968,029	$7,024,237
Depreciation Amortization Depletion	$487,488	$563,758	$659,826	$693,314
Depreciation And Amortization	$487,488	$563,758	$659,826	$693,314
Amortization Cash Flow	$18,551	$49,024	$111,636	$114,202
Amortization Of Intangibles	$18,551	$49,024	$111,636	$114,202
Depreciation	$468,937	$514,734	$548,188	$579,112
Gain Loss On Investment Securities	$-6,605,387	-	-	-
Net Foreign Currency Exchange Gain Loss	$7,420,815	$-43,116	$479,973	$447,832
Net Income From Continuing Operations	$-53,031,705	$-53,532,137	$-49,584,580	$-34,264,512

Fetched: 2026-08-31